SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-22-038767
Filing Date
2022-07-12
Accepted
2022-07-12 12:12:02
Documents
1
Group Members
3D OPPORTUNITY MASTER FUND

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea162638-sc13da_3dinvestment.htm SC 13D/A 37481
  Complete submission text file 0001213900-22-038767.txt   39087
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Subject) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81409 | Film No.: 221078652
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 NORTH BRIDGE ROAD #13-01 RAFFLES CITY TOWER SINGAPORE U0 179101
Business Address 250 NORTH BRIDGE ROAD #13-01 RAFFLES CITY TOWER SINGAPORE U0 179101 65 6819 0000
3D Investment Partners Pte. Ltd. (Filed by) CIK: 0001841538 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D/A